References
- Abdelhafez OM, Amin KM, Ali HI, Abdalla MM, Batran RZ. 2012. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors. J. Med. Chem. 55: 10424-10436. https://doi.org/10.1021/jm301014y
- Bautista-Aguilera OM, Samadi A, Chioua M, Nikolic K, Filipic S, Agbaba D, et al. 2014. N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl) prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor. J. Med. Chem. 57: 10455-10463. https://doi.org/10.1021/jm501501a
- Berlin I, Zimmer R, Thiede HM, Payan C, Hergueta T, Robin L, Puech AJ. 1990. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br. J. Clin. Pharmacol. 30: 805-816. https://doi.org/10.1111/j.1365-2125.1990.tb05445.x
- Callebert J, Esteve JM, Hervé P, Peoc'h K, Tournois C, Drouet L, et al. 2006. Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine (2B) receptors in mice. J. Pharmacol. Exp. Ther. 317: 724-731. https://doi.org/10.1124/jpet.105.098269
- Doly S, Valjent E, Setola V, Callebert J, Hervé D, Launay JM, Maroteaux L. 2008. Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J. Neurosci. 28: 2933-2940. https://doi.org/10.1523/JNEUROSCI.5723-07.2008
- Fenical W, Jensen PR. 2006. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2: 666-673. https://doi.org/10.1038/nchembio841
- Ferino G, Vilar S, Matos MJ, Uriarte E, Cadoni E. 2012. Monoamine oxidase inhibitors: ten years of docking studies. Curr. Top. Med. Chem. 12: 2145-2162. https://doi.org/10.2174/156802612805220048
- Finberg JP. 2014. Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol. Ther. 143: 133-152. https://doi.org/10.1016/j.pharmthera.2014.02.010
- Fowler JS, Logan J, Azzaro AJ, Fielding RM, Zhu W, Poshusta AK, et al. 2010. Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAOA by CX157. Neuropsychopharmacology 35: 623-631. https://doi.org/10.1038/npp.2009.167
- Gentili F, Pizzinat N, Ordener C, Marchal-Victorion S, Maurel A, Hofmann R, et al. 2006. 3-[5-(4,5-Dihydro-1Himidazol-2-yl)-furan-2-yl]phenylamine (amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. J. Med. Chem. 49: 5578-5586. https://doi.org/10.1021/jm060605r
- Kim H, Sablin SO, Ramsay RR. 1997. Inhibition of monoamine oxidase A by β-carboline derivatives. Arch. Biochem. Biophys. 337: 137-142. https://doi.org/10.1006/abbi.1996.9771
- Kim H, Yang I, Patil RS, Kang S, Lee J, Choi H, et al. 2014. Anithiactins AC, modified 2-phenylthiazoles from a mudflatderived Streptomyces sp. J. Nat. Prod. 77: 2716-2719. https://doi.org/10.1021/np500558b
- Lin Z, Antemano RR, Hughen RW, Tianero MD, Peraud O, Haygood MG, et al. 2010. Pulicatins A-E, neuroactive thiazoline metabolites from cone snail-associated bacteria. J. Nat. Prod. 73: 1922-1926. https://doi.org/10.1021/np100588c
- Lotufo-Neto F, Trivedi M, Thase ME. 1999. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Neuropsychopharmacology 20: 226-247. https://doi.org/10.1016/S0893-133X(98)00075-X
- Malcomson T, Yelekci K, Borrello MT, Ganesan A, Semina E, De Kimpe N, et al. 2015. cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases. FEBS J. DOI: 10.1111/febs.13260 [Epub ahead of print].
- Mattsson C, Svensson P, Sonesson C. 2014. A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. Eur. J. Med. Chem. 73: 177-186. https://doi.org/10.1016/j.ejmech.2013.11.035
- Moon K, Chung B, Shin Y, Rheingold AL, Moore CE, Park SJ, et al. 2015. Pentacyclic antibiotics from a tidal mud flatderived actinomycete. J. Nat. Prod. 78: 524-529. https://doi.org/10.1021/np500736b
- Mostert S, Petzer A, Petzer JP. 2015. Indanones as high-potency reversible inhibitors of monoamine oxidase. ChemMedChem DOI: 10.1002/cmdc.201500059 [Epub ahead of print].
- Pan HQ, Yu SY, Song CF, Wang N, Hua HM, Hu JC, Wang SJ. 2015. Identification and characterization of the antifungal substances of a novel Streptomyces cavourensis NA4. J. Microbiol. Biotechnol. 25: 353-357. https://doi.org/10.4014/jmb.1407.07025
- Parsons CG, Danysz W, Dekundy A, Pulte I. 2013. Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer’s disease. Neurotox. Res. 24: 358-369. https://doi.org/10.1007/s12640-013-9398-z
- Ramsay RR. 2012. Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery. Curr. Top. Med. Chem. 12: 2189-2209. https://doi.org/10.2174/156802612805219978
- Ramsay RR. 2013. Inhibitor design for monoamine oxidases. Curr. Pharm. Des. 19: 2529-2539. https://doi.org/10.2174/1381612811319140004
- Stevens H, Brinkhoff T, Rink B, Vollmers J, Simon M. 2007. Diversity and abundance of gram positive bacteria in a tidal flat ecosystem. Environ. Microbiol. 9: 1810-1822. https://doi.org/10.1111/j.1462-2920.2007.01302.x
- Yang W, Dostal L, Rosazza JP. 1993. Aeruginol [2-(2’-hydroxyphenyl)-4-hydroxymethylthiazole], a new secondary metabolite from Pseudomonas aeruginosa. J. Nat. Prod. 56: 1993-1994. https://doi.org/10.1021/np50101a021
- Youdim MB, Edmondson D, Tipton KF. 2006. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7: 295-309. https://doi.org/10.1038/nrn1883
Cited by
- One-Pot Synthesis of 5-Hydroxy-4H-1,3-thiazin-4-ones: Structure Revision, Synthesis, and NMR Shift Dependence of Thiasporine A vol.18, pp.13, 2015, https://doi.org/10.1021/acs.orglett.6b01166
- Potent Inhibition of Monoamine Oxidase B by a Piloquinone from Marine-Derived Streptomyces sp. CNQ-027 vol.27, pp.4, 2017, https://doi.org/10.4014/jmb.1612.12025
- Potent Selective Inhibition of Monoamine Oxidase A by Alternariol Monomethyl Ether Isolated from Alternaria brassicae vol.27, pp.2, 2015, https://doi.org/10.4014/jmb.1610.10053
- Chromenone Derivatives as Monoamine Oxidase Inhibitors from Marine-Derived MAR4 Clade Streptomyces sp. CNQ-031 vol.31, pp.7, 2021, https://doi.org/10.4014/jmb.2105.05003